Literature DB >> 23585509

Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study.

Rhea Powell1, Duncan Davidson1, Jasmin Divers2, Ani Manichaikul3, J Jeffrey Carr4, Robert Detrano5, Eric A Hoffman6, Rui Jiang1, Richard A Kronmal7, Kiang Liu8, Naresh M Punjabi9, Eyal Shahar10, Karol E Watson11, Jerome I Rotter12, Kent D Taylor12, Stephen S Rich3, R Graham Barr1,13.   

Abstract

BACKGROUND: Cigarette smoking is the major cause of chronic obstructive pulmonary disease and emphysema. Recent studies suggest that susceptibility to cigarette smoke may vary by race/ethnicity; however, they were generally small and relied on self-reported race/ethnicity.
OBJECTIVE: To test the hypothesis that relationships of smoking to lung function and per cent emphysema differ by genetic ancestry and self-reported race/ethnicity among Caucasians, African-Americans, Hispanics and Chinese-Americans.
DESIGN: Cross-sectional population-based study of adults age 45-84 years in the USA. MEASUREMENTS: Principal components of genetic ancestry and continental ancestry estimated from one million genome-wide single nucleotide polymorphisms; pack-years of smoking; spirometry measured for 3344 participants; and per cent emphysema on computed tomography for 8224 participants.
RESULTS: The prevalence of ever-smoking was: Caucasians, 57.6%; African-Americans, 56.4%; Hispanics, 46.7%; and Chinese-Americans, 26.8%. Every 10 pack-years was associated with -0.73% (95% CI -0.90% to -0.56%) decrement in the forced expiratory volume in 1 s to forced vital capacity (FEV1 to FVC) and a 0.23% (95% CI 0.08% to 0.38%) increase in per cent emphysema. There was no evidence that relationships of pack-years to the FEV1 to FVC, airflow obstruction and per cent emphysema varied by genetic ancestry (all p>0.10), self-reported race/ethnicity (all p>0.10) or, among African-Americans, African ancestry. There were small differences in relationships of pack-years to the FEV1 among male Chinese-Americans and to the FEV1 to FVC ratio with African and Native American ancestry among male Hispanics only.
CONCLUSIONS: In this large cohort, there was little to no evidence that the associations of smoking to lung function and per cent emphysema differed by genetic ancestry or self-reported race/ethnicity.

Entities:  

Keywords:  COPD epidemiology; Emphysema; Tobacco and the lung

Mesh:

Year:  2013        PMID: 23585509      PMCID: PMC4020409          DOI: 10.1136/thoraxjnl-2012-202116

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  37 in total

1.  Genetic ancestry in lung-function predictions.

Authors:  Rajesh Kumar; Max A Seibold; Melinda C Aldrich; L Keoki Williams; Alex P Reiner; Laura Colangelo; Joshua Galanter; Christopher Gignoux; Donglei Hu; Saunak Sen; Shweta Choudhry; Edward L Peterson; Jose Rodriguez-Santana; William Rodriguez-Cintron; Michael A Nalls; Tennille S Leak; Ellen O'Meara; Bernd Meibohm; Stephen B Kritchevsky; Rongling Li; Tamara B Harris; Deborah A Nickerson; Myriam Fornage; Paul Enright; Elad Ziv; Lewis J Smith; Kiang Liu; Esteban González Burchard
Journal:  N Engl J Med       Date:  2010-07-07       Impact factor: 91.245

2.  Atlas-driven lung lobe segmentation in volumetric X-ray CT images.

Authors:  Li Zhang; Eric A Hoffman; Joseph M Reinhardt
Journal:  IEEE Trans Med Imaging       Date:  2006-01       Impact factor: 10.048

3.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

4.  New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites.

Authors:  Shannon Bruse; Akshay Sood; Hans Petersen; Yushi Liu; Shuguang Leng; Juan C Celedón; Frank Gilliland; Bartolomé Celli; Steven A Belinsky; Yohannes Tesfaigzi
Journal:  Am J Respir Crit Care Med       Date:  2011-09-08       Impact factor: 21.405

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

8.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease.

Authors:  D J Barker; K M Godfrey; C Fall; C Osmond; P D Winter; S O Shaheen
Journal:  BMJ       Date:  1991-09-21

9.  Menthol cigarettes and health risks in Lung Health Study data.

Authors:  Robert P Murray; John E Connett; Melissa A Skeans; Donald P Tashkin
Journal:  Nicotine Tob Res       Date:  2007-01       Impact factor: 4.244

10.  Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study.

Authors:  W M Vollmer; Thorn Gíslason; P Burney; P L Enright; A Gulsvik; A Kocabas; A S Buist
Journal:  Eur Respir J       Date:  2009-05-21       Impact factor: 16.671

View more
  16 in total

1.  Obstructive lung disease in Mexican Americans and non-Hispanic whites: an analysis of diagnosis and survival in the National Health and Nutritional Examination Survey III Follow-up Study.

Authors:  Alejandro A Diaz; Carolyn E Come; David M Mannino; Victor Pinto-Plata; Miguel J Divo; Carol Bigelow; Bartolome Celli; George R Washko
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

2.  A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.

Authors:  Elizabeth C Oelsner; Victor E Ortega; Benjamin M Smith; Jennifer N Nguyen; Ani W Manichaikul; Eric A Hoffman; Xiuqing Guo; Kent D Taylor; Prescott G Woodruff; David J Couper; Nadia N Hansel; Fernando J Martinez; Robert Paine; Meilan K Han; Christopher Cooper; Mark T Dransfield; Gerard Criner; Jerry A Krishnan; Russell Bowler; Eugene R Bleecker; Stephen Peters; Stephen S Rich; Deborah A Meyers; Jerome I Rotter; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

Review 3.  Chronic Obstructive Pulmonary Disease in Hispanics. A 9-Year Update.

Authors:  Alejandro A Díaz; Bartolomé Celli; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

4.  Differences in Respiratory Symptoms and Lung Structure Between Hispanic and Non-Hispanic White Smokers: A Comparative Study.

Authors:  Alejandro A Diaz; Farbod N Rahaghi; Tracy J Doyle; Thomas P Young; Erick S Maclean; Carlos H Martinez; Raul San José Estépar; Stefano Guerra; Yohannes Tesfaigzi; Ivan O Rosas; George R Washko; David O Wilson
Journal:  Chronic Obstr Pulm Dis       Date:  2017-09-05

5.  Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study.

Authors:  Elizabeth C Oelsner; Eric A Hoffman; Aaron R Folsom; J Jeffrey Carr; Paul L Enright; Steven M Kawut; Richard Kronmal; David Lederer; Joao A C Lima; Gina S Lovasi; Steven Shea; R Graham Barr
Journal:  Ann Intern Med       Date:  2014-12-16       Impact factor: 25.391

6.  Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial.

Authors:  Adam Bress; Rick Kittles; Coady Wing; Stanley E Hooker; Andrea King
Journal:  Pharmacogenet Genomics       Date:  2015-06       Impact factor: 2.089

Review 7.  Establishing normal reference values in quantitative computed tomography of emphysema.

Authors:  Benjamin M Smith; Robert Graham Barr
Journal:  J Thorac Imaging       Date:  2013-09       Impact factor: 3.000

8.  Human airway branch variation and chronic obstructive pulmonary disease.

Authors:  Benjamin M Smith; Hussein Traboulsi; John H M Austin; Ani Manichaikul; Eric A Hoffman; Eugene R Bleecker; Wellington V Cardoso; Christopher Cooper; David J Couper; Stephen M Dashnaw; Jia Guo; MeiLan K Han; Nadia N Hansel; Emlyn W Hughes; David R Jacobs; Richard E Kanner; Joel D Kaufman; Eric Kleerup; Ching-Long Lin; Kiang Liu; Christian M Lo Cascio; Fernando J Martinez; Jennifer N Nguyen; Martin R Prince; Stephen Rennard; Stephen S Rich; Leora Simon; Yanping Sun; Karol E Watson; Prescott G Woodruff; Carolyn J Baglole; R Graham Barr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

9.  Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of Latinos.

Authors:  R Graham Barr; Larissa Avilés-Santa; Sonia M Davis; Tom K Aldrich; Franklyn Gonzalez; Ashley G Henderson; Robert C Kaplan; Lisa LaVange; Kiang Liu; Jose S Loredo; Eliana S Mendes; Ai Ni; Andrew Ries; Matthias Salathe; Lewis J Smith
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

10.  Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.

Authors:  Michael H Cho; Merry-Lynn N McDonald; Xiaobo Zhou; Manuel Mattheisen; Peter J Castaldi; Craig P Hersh; Dawn L Demeo; Jody S Sylvia; John Ziniti; Nan M Laird; Christoph Lange; Augusto A Litonjua; David Sparrow; Richard Casaburi; R Graham Barr; Elizabeth A Regan; Barry J Make; John E Hokanson; Sharon Lutz; Tanda Murray Dudenkov; Homayoon Farzadegan; Jacqueline B Hetmanski; Ruth Tal-Singer; David A Lomas; Per Bakke; Amund Gulsvik; James D Crapo; Edwin K Silverman; Terri H Beaty
Journal:  Lancet Respir Med       Date:  2014-02-07       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.